These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1904694)

  • 41. [Lethal familial neonatal ketotic hyperammonemia].
    Pauli A; Huguet J; Rollet M; Cousin J; Farriaux JP; Fournier A; Navarro J; Cathelineau L; Aymard P; Saudubray JM; Polonovski C; Laplane R
    Arch Fr Pediatr; 1972; 29(7):699-712. PubMed ID: 4644460
    [No Abstract]   [Full Text] [Related]  

  • 42. Hyperlysinemia with saccharopinuria due to combined lysine-ketoglutarate reductase and saccharopine dehydrogenase deficiencies presenting as cystinuria.
    Cederbaum SD; Shaw KN; Dancis J; Hutzler J; Blaskovics JC
    J Pediatr; 1979 Aug; 95(2):234-8. PubMed ID: 571908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Excretion of pipecolic acid by infants and by patients with hyperlysinemia.
    Woody NC; Pupene MB
    Pediatr Res; 1970 Jan; 4(1):89-95. PubMed ID: 5417004
    [No Abstract]   [Full Text] [Related]  

  • 44. [Glutaric aciduria type I: an organic acidemia without acidosis with severe movement disorders].
    Prats Viñas J
    Neurologia; 2001 Oct; 16(8):337-41. PubMed ID: 11738010
    [No Abstract]   [Full Text] [Related]  

  • 45. Simultaneous quantification of alpha-aminoadipic semialdehyde, piperideine-6-carboxylate, pipecolic acid and alpha-aminoadipic acid in pyridoxine-dependent epilepsy.
    Xue J; Wang J; Gong P; Wu M; Yang W; Jiang S; Wu Y; Jiang Y; Zhang Y; Yuzyuk T; Li H; Yang Z
    Sci Rep; 2019 Aug; 9(1):11371. PubMed ID: 31388081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Urea cycle disorders].
    Tazawa Y
    Ryoikibetsu Shokogun Shirizu; 1995; (8):367-9. PubMed ID: 8581654
    [No Abstract]   [Full Text] [Related]  

  • 47. D-2-hydroxyglutaric aciduria: evidence of clinical and biochemical heterogeneity.
    Wagner L; Hoffmann GF; Jakobs C
    J Inherit Metab Dis; 1998 Jun; 21(3):247-50. PubMed ID: 9686368
    [No Abstract]   [Full Text] [Related]  

  • 48. The significance of hyperpipecolatemia in Zellweger syndrome.
    Dancis J; Hutzler J
    Am J Hum Genet; 1986 May; 38(5):707-11. PubMed ID: 3087161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complementary dietary treatment using lysine-free, arginine-fortified amino acid supplements in glutaric aciduria type I - A decade of experience.
    Kölker S; Boy SP; Heringer J; Müller E; Maier EM; Ensenauer R; Mühlhausen C; Schlune A; Greenberg CR; Koeller DM; Hoffmann GF; Haege G; Burgard P
    Mol Genet Metab; 2012 Sep; 107(1-2):72-80. PubMed ID: 22520952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Diseases caused by altered intermediate metabolism of amino acids].
    Bulgarelli R; Berio A
    Minerva Nipiol; 1969; 19(6):328-61 contd. PubMed ID: 4923874
    [No Abstract]   [Full Text] [Related]  

  • 51. Homocitrullinuria and homoargininuria in lysinuric protein intolerance.
    Kato T; Sano M; Mizutani N
    J Inherit Metab Dis; 1989; 12(2):157-61. PubMed ID: 2474087
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1.
    Leandro J; Khamrui S; Suebsuwong C; Chen PJ; Secor C; Dodatko T; Yu C; Sanchez R; DeVita RJ; Houten SM; Lazarus MB
    Open Biol; 2022 Sep; 12(9):220179. PubMed ID: 36128717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Amino acid transfer systems and their importance in pathology. II. Specific abnormalities in renal and intestinal amino acid transfer].
    Boisse J; Moatti N
    Ann Biol Clin (Paris); 1973; 31(4):249-55. PubMed ID: 4579284
    [No Abstract]   [Full Text] [Related]  

  • 54. A survey of inborn errors of amino acid metabolism and transport in man.
    Wellner D; Meister A
    Annu Rev Biochem; 1981; 50():911-68. PubMed ID: 6791581
    [No Abstract]   [Full Text] [Related]  

  • 55. Detection of inborn errors of metabolism using GC-MS: over 3 years of experience in southern China.
    Jiang M; Liu L; Mei H; Li X; Cheng J; Cai Y
    J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):375-80. PubMed ID: 25781538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyperammonemia in lysinuric protein intolerance.
    Kato T; Mizutani N; Ban M
    Pediatrics; 1984 Apr; 73(4):489-92. PubMed ID: 6424086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recurrent stupor due to lysinuric protein intolerance.
    Moosa NV; Minal D; Rao AN; Kumar A
    Neurol India; 2005 Sep; 53(3):333-4. PubMed ID: 16230804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Carnitine deficiency in lysinuric protein intolerance: lysine-sparing effect of carnitine.
    Takada G; Goto A; Komatsu K; Goto R
    Tohoku J Exp Med; 1987 Dec; 153(4):331-4. PubMed ID: 3126568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyperlysinuria with hyperammonemia. A new metabolic disorder.
    Brown JH; Fabre LF; Farrell GL; Adams ED
    Am J Dis Child; 1972 Jul; 124(1):127-32. PubMed ID: 5033744
    [No Abstract]   [Full Text] [Related]  

  • 60. Leukocyte and liver glutaminase in lysinuric protein intolerance.
    Simell O; Perheentupa J; Visakorpi JK
    Pediatr Res; 1972 Oct; 6(10):797-801. PubMed ID: 4648974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.